Mastodon

Glaucin (Dragee, Syrup) Instructions for Use

ATC Code

R05DB (Other antitussive drugs)

Active Substance

Glaucine (BP British Pharmacopoeia)

Clinical-Pharmacological Group

Antitussive drug

Pharmacotherapeutic Group

Central antitussive agent

Pharmacological Action

Antitussive agent of central action. An alkaloid of the plant Yellow Horned Poppy (Glaucium flavum).

Unlike codeine, it does not depress the respiratory center, does not suppress intestinal motor activity; with prolonged use, it does not cause drug dependence or habituation.

It has adrenolytic properties and may cause a decrease in blood pressure.

Indications

  • Cough of various etiologies, including in infectious and inflammatory diseases of the upper respiratory tract, bronchi and lungs.
  • Use in bronchial asthma, pleurisy, whooping cough, tuberculosis, and lung cancer.

ICD codes

ICD-10 code Indication
A15 Respiratory tuberculosis, bacteriologically and histologically confirmed
A37 Whooping cough
C34 Malignant neoplasm of bronchus and lung
J04 Acute laryngitis and tracheitis
J15 Bacterial pneumonia, not elsewhere classified
J20 Acute bronchitis
J37 Chronic laryngitis and laryngotracheitis
J42 Unspecified chronic bronchitis
J45 Asthma
R05 Cough
R09.1 Pleurisy
ICD-11 code Indication
1B10.0 Respiratory tuberculosis, bacteriologically or histologically confirmed
1C12.Z Whooping cough, unspecified
2C25.Z Malignant neoplasms of bronchus or lung, unspecified
CA05 Acute laryngitis or tracheitis
CA0G Chronic laryngitis or laryngotracheitis
CA20.1Z Chronic bronchitis, unspecified
CA23 Asthma
CA40.0Z Bacterial pneumonia, unspecified
CA42.Z Acute bronchitis, unspecified
MD12 Cough
MD31 Pleurisy

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

For adults, administer a single dose of 40 mg orally 2-3 times/day to suppress cough. To control severe night cough, administer a single dose of 80 mg at bedtime. Do not exceed the maximum daily dose of 200 mg.

For children over 4 years of age, administer a single dose of 10 mg orally 2-3 times/day. Administer all doses after meals to improve tolerability.

Adverse Reactions

Adverse reactions are infrequent and typically associated with higher doses. Dizziness, weakness, nausea, and decreased blood pressure may occur, particularly after a single 80 mg dose.

Monitor for potential allergic reactions. Discontinue use if severe adverse reactions develop.

Contraindications

  • Do not use in patients with known hypersensitivity to the active substance or any excipient.
  • Contraindicated in arterial hypotension and in the acute phase of myocardial infarction due to adrenolytic properties.
  • Avoid use in conditions with significant hypersecretion of sputum where cough suppression is undesirable.

Pediatric Use

Not recommended for use in children under 4 years of age.

Special Precautions

Not recommended for use in children under 4 years of age.

Drug Interactions

This agent can be administered in combination with ephedrine hydrochloride, citric acid, and basil oil amber without known significant pharmacokinetic interactions.

Exercise caution with concomitant use of other centrally acting drugs or antihypertensive agents due to potential additive effects on blood pressure and the central nervous system.

Overdose

Symptoms of overdose may include pronounced dizziness, severe hypotension, marked weakness, and nausea.

In case of overdose, implement symptomatic and supportive measures, with particular attention to managing blood pressure. There is no specific antidote.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Jaka-80 (Macedonia)

Dosage Form

Bottle Rx Icon Glaucine Dragees 40 mg: 20 pcs.

Dosage Form, Packaging, and Composition

Dragee 1 dragee
Glaucine phosphate 40 mg

20 pcs. – blister packs (1) – cardboard packs.

Marketing Authorization Holder

Jaka-80 (Macedonia)

Dosage Form

Bottle Rx Icon Glaucine Syrup 40 mg/15 ml: bottle 150 ml

Dosage Form, Packaging, and Composition

Syrup 15 ml
Glaucine phosphate 40 mg

150 ml – dark glass bottles (1) – cardboard packs.

Marketing Authorization Holder

Jaka-80 (Macedonia)

Dosage Form

Bottle Rx Icon Glaucine Syrup (for children) 5 mg/5 ml: bottle 60 ml

Dosage Form, Packaging, and Composition

Syrup for children 5 ml
Glaucine phosphate 5 mg

60 ml – dark glass bottles (1) – cardboard packs.

TABLE OF CONTENTS